Marlborough biotech firm Advanced Cell Technology said it has picked up $30 million in capital through a common stock purchase agreement with a Chicago-based investment firm. The deal, with Lincoln ...

The NCAA Track and Field Championships took place last Wednesday at Hayward Field as redshirt freshman Ben Smith came out on top in the men’s... WASHINGTON (KRT) ­ A Massachusetts company said Sunday ...

LOS ANGELES (Reuters) - Biotechnology company Advanced Cell Technology Inc. plans to publish in the first half of this year data from trials in animals of its stem cell-based therapies for macular ...

Ocata Therapeutics of Marlborough, which researches treatments for eye diseases, has agreed to be sold to Astellas Pharma Inc. of Japan for $379 million, the two companies announced late Monday.